A federal lawsuit filed by West Virginia and 43 other states against Mylan Pharmaceuticals has been transferred from the federal court in Connecticut to U.S. District Court for the Eastern District of Pennsylvania at Philadelphia.
In a conditional transfer order, John W. Nichols, the clerk of the U.S. Judicial Panel on Multidistrict Litigation, noted that since Aug. 5, 2016, the panel transferred a total of 45 actions to the Eastern District of Pennsylvania involving the antitrust litigation. All of the actions have been assigned to District Judge Cynthia M. Rufe.
“Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Eastern District of Pennsylvania for the reasons stated in the order of August 5, 2016, and, with the consent of that court, assigned to the Honorable Cynthia M. Rufe,” the order states.
The states filed the antitrust lawsuit alleging the nation’s largest generic drug companies conspired to inflate and manipulate prices, cut competition and restrain trade for more than 100 different drugs.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
